Table 7.

Predictors of intensive care unit stay during hospitalization

	Univariate analysis		Multivariate analysis
Variables	OR (95% CI)	P value	OR (95% CI)	P value
Age	1.01 (0.97–1.04)	0.69
Male gender	0.88 (0.32–2.43)	0.81
Predisposing disease
Malignancy	1.06 (0.39–2.88)	0.91
Liver cirrhosis	3.38 (1.02–11.22)	0.047	3.45 (0.79–14.99)	0.1
Diabetes mellitus	3.50 (1.21–10.14)	0.021	3.72 (1.01–13.70)	0.048
Medication
Proton-pump inhibitor use	1.39 (0.44–4.39)	0.57
Immunosuppression	4.11 (1.27–13.37)	0.019
Blood values
C-reactive Protein	1.02 (0.97–1.07)	0.37
WBC	1.03 (0.97–1.09)	0.29
Bilirubin	1.06 (0.95–1.18)	0.29
Creatinine	1.82 (0.87–3.82)	0.11
INR	6.74 (0.67–67.24)	0.10
Cholangitis	1.64 (0.62–4.36)	0.32
MDRO	1.08 (0.36–3.29)	0.89
Mycotic coinfection	3.92 (1.33–11.55)	0.013	5.54 (1.46–21.06)	0.012
Initial empirical antibiotic treatment
Carbapenem based	4.37 (1.49–12.81)	0.007	3.73 (1.09–12.89)	0.037
Glycopeptide based	3.35 (1.21–9.25)	0.019
Tigecycline based	2.14 (0.43–10.58)	0.35
Metronidazole based	0.42 (0.11–1.64)	0.21